Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Diaphragm Pacing Therapy System Market by Product Type (External Diaphragm Pacemaker, Diaphragm Pacemaker), by Applications (SCI, ALS, Other) and by Methods (Intrathoracic Diaphragm Pacing (IT-DP), Intraperitoneal Diaphragm Pacing): Global Opportunity Analysis and Industry Forecast, 2023-2032

A08430

Pages: NA

Charts: NA

Tables: NA

Diaphragm pacing systems are battery-powered pacing systems that run on electricity, are lightweight, and help in the stimulation of diaphragm nerves and muscles. They help the diaphragm in contracting, which allows the air to enter the lungs. This allows the patient to breathe normally.

Various lung pacer diaphragm pacing therapy systems(DPTS) got urgent approval from the FDA as they were needed in healthcare settings to provide mechanical ventilation for patient’s treatment. This device helps in the stimulation of phrenic nerves for diaphragm activation in adults.These patients use ventilation by using mechanics. These devices are used for temporary purposes, are transvenous, placed percutaneously, and are phrenic nerve-stimulating device. Furthermore, they are used in hospitals and other healthcare facilities by trained and qualified officials.

COVID-19 scenario analysis:

  • Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs, such as hydroxychloroquine, have witnessed a dramatic surge in demand for the management of COVID-19.
  • Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs as many developed countries are short of these drugs. The pharmaceutical and biotechnology industries are expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19.
  • Attributed to such factors, COVID-19 is expected to have a significant impact on the market.

Top impacting factors: Market scenario analysis, trends, drivers and impact analysis

Significant increase in Invasive Mechanical Ventilation (IMV) complexities, which results in injuries related to lungs, infections, and muscle atrophy; increased frequencies of amyotrophic lateral sclerosis (ALS) and spinal cord injuries (SCI); and other benefits of diaphragm pacing therapy system (DPTS) such as dependency reduction on mechanical ventilators; betterment in breathing and speech in patients are the major factors that propel the growth of the diaphragm pacing therapy system market.

Additionally, the current crisis of global COVID-19 also increases the demand and consumption of mechanical ventilators.A rise has been observed in patients suffering from respiratory diseases due to changing lifestyle and environmental conditions, which affect the growth of the diaphragm pacing therapy system market. Furthermore, the regulatory policies also prove to be beneficial to the diaphragm pacing therapy system market.On the other hand, high prices for production and prolonged approval period are the major challenges faced by the key players of the diaphragm pacing therapy system market.

New product launches and acquisitions to boost the market

On April 14th, 2020, Lungpacer Medical got approval from the U.S. FDA. This was an emergency use authorization approval. Diaphragm pacing therapy systems are being used to help patients suffering from COVID-19. Additionally, onMay 11th, 2016, Lungpacer Diaphragm Pacing System got an approval from the Expedited Access Pathway (EPA) Designation by the U.S. FDA

Surge in usage in hospitalapplications

Hospitals, ambulatory surgical centers, and others are the major consumers of the diaphragm pacing therapy system. Amongst them, hospitals are the biggest end users in the market. This is attributed to the SCI,which help in raising the popularity, owing to the rise in number and frequency of cases related to SCIs.

Additionally, accidents or crashes during driving and sports activities also increase the admission of patients in hospitals who subsequently need diaphragm pacing therapy systems.

Key benefits of the report:

  • This study presents the analytical depiction of the diaphragm pacing therapy system marketalong with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the diaphragm pacing therapy system market share.
  • The current market is quantitatively analyzed to highlight the diaphragm pacing therapy system market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the diaphragm pacing therapy system market research report:

  • Which are the leading market players active in the market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What are the projections for the future that would help in taking further strategic steps?

 Key Market Segments

  • By Product Type
    • External Diaphragm Pacemaker
    • Diaphragm Pacemaker
  • By Applications
    • SCI
    • ALS
    • Other
  • By Methods
    • Intrathoracic Diaphragm Pacing (IT-DP)
    • Intraperitoneal Diaphragm Pacing
  • By Region
    • North America
      • US
      • Canada
    • Europe
      • Germany
      • UK
      • France
      • rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • rest of Asia-Pacific
    • Latin America
      • Brazil
      • Mexico
      • rest of LATAM
    • the Middle East
    • Africa

 
Key Market Players

  • Synapse Biomedical
  • Ikaria
  • MedImmune
  • Arahelio
  • PneumRx
  • Pulmonx
  • Actelion
  • Aeris
  • Lungpacer Medical, Inc
  • Novartis
  • Respironics
  • AstraZeneca
  • Avery Biomedical Devices
  • Forest
  • Atrotech
  • Pearl
  • Boehringer Ingelheim

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: DIAPHRAGM PACING THERAPY SYSTEM MARKET, BY PRODUCT TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product Type

    • 4.2. External Diaphragm Pacemaker

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Diaphragm Pacemaker

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: DIAPHRAGM PACING THERAPY SYSTEM MARKET, BY APPLICATIONS

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Applications

    • 5.2. SCI

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. ALS

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Other

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: DIAPHRAGM PACING THERAPY SYSTEM MARKET, BY METHODS

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Methods

    • 6.2. Intrathoracic Diaphragm Pacing (IT-DP)

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Intraperitoneal Diaphragm Pacing

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

  • CHAPTER 7: DIAPHRAGM PACING THERAPY SYSTEM MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Product Type

      • 7.2.3. Market Size and Forecast, By Applications

      • 7.2.4. Market Size and Forecast, By Methods

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Diaphragm Pacing Therapy System Market

        • 7.2.6.1. Market Size and Forecast, By Product Type
        • 7.2.6.2. Market Size and Forecast, By Applications
        • 7.2.6.3. Market Size and Forecast, By Methods

      • 7.2.7. Canada Diaphragm Pacing Therapy System Market

        • 7.2.7.1. Market Size and Forecast, By Product Type
        • 7.2.7.2. Market Size and Forecast, By Applications
        • 7.2.7.3. Market Size and Forecast, By Methods

      • 7.2.8. Mexico Diaphragm Pacing Therapy System Market

        • 7.2.8.1. Market Size and Forecast, By Product Type
        • 7.2.8.2. Market Size and Forecast, By Applications
        • 7.2.8.3. Market Size and Forecast, By Methods

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Product Type

      • 7.3.3. Market Size and Forecast, By Applications

      • 7.3.4. Market Size and Forecast, By Methods

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Diaphragm Pacing Therapy System Market

        • 7.3.6.1. Market Size and Forecast, By Product Type
        • 7.3.6.2. Market Size and Forecast, By Applications
        • 7.3.6.3. Market Size and Forecast, By Methods

      • 7.3.7. Germany Diaphragm Pacing Therapy System Market

        • 7.3.7.1. Market Size and Forecast, By Product Type
        • 7.3.7.2. Market Size and Forecast, By Applications
        • 7.3.7.3. Market Size and Forecast, By Methods

      • 7.3.8. Italy Diaphragm Pacing Therapy System Market

        • 7.3.8.1. Market Size and Forecast, By Product Type
        • 7.3.8.2. Market Size and Forecast, By Applications
        • 7.3.8.3. Market Size and Forecast, By Methods

      • 7.3.9. Spain Diaphragm Pacing Therapy System Market

        • 7.3.9.1. Market Size and Forecast, By Product Type
        • 7.3.9.2. Market Size and Forecast, By Applications
        • 7.3.9.3. Market Size and Forecast, By Methods

      • 7.3.10. UK Diaphragm Pacing Therapy System Market

        • 7.3.10.1. Market Size and Forecast, By Product Type
        • 7.3.10.2. Market Size and Forecast, By Applications
        • 7.3.10.3. Market Size and Forecast, By Methods

      • 7.3.11. Russia Diaphragm Pacing Therapy System Market

        • 7.3.11.1. Market Size and Forecast, By Product Type
        • 7.3.11.2. Market Size and Forecast, By Applications
        • 7.3.11.3. Market Size and Forecast, By Methods

      • 7.3.12. Rest Of Europe Diaphragm Pacing Therapy System Market

        • 7.3.12.1. Market Size and Forecast, By Product Type
        • 7.3.12.2. Market Size and Forecast, By Applications
        • 7.3.12.3. Market Size and Forecast, By Methods

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Product Type

      • 7.4.3. Market Size and Forecast, By Applications

      • 7.4.4. Market Size and Forecast, By Methods

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Diaphragm Pacing Therapy System Market

        • 7.4.6.1. Market Size and Forecast, By Product Type
        • 7.4.6.2. Market Size and Forecast, By Applications
        • 7.4.6.3. Market Size and Forecast, By Methods

      • 7.4.7. Japan Diaphragm Pacing Therapy System Market

        • 7.4.7.1. Market Size and Forecast, By Product Type
        • 7.4.7.2. Market Size and Forecast, By Applications
        • 7.4.7.3. Market Size and Forecast, By Methods

      • 7.4.8. India Diaphragm Pacing Therapy System Market

        • 7.4.8.1. Market Size and Forecast, By Product Type
        • 7.4.8.2. Market Size and Forecast, By Applications
        • 7.4.8.3. Market Size and Forecast, By Methods

      • 7.4.9. South Korea Diaphragm Pacing Therapy System Market

        • 7.4.9.1. Market Size and Forecast, By Product Type
        • 7.4.9.2. Market Size and Forecast, By Applications
        • 7.4.9.3. Market Size and Forecast, By Methods

      • 7.4.10. Australia Diaphragm Pacing Therapy System Market

        • 7.4.10.1. Market Size and Forecast, By Product Type
        • 7.4.10.2. Market Size and Forecast, By Applications
        • 7.4.10.3. Market Size and Forecast, By Methods

      • 7.4.11. Thailand Diaphragm Pacing Therapy System Market

        • 7.4.11.1. Market Size and Forecast, By Product Type
        • 7.4.11.2. Market Size and Forecast, By Applications
        • 7.4.11.3. Market Size and Forecast, By Methods

      • 7.4.12. Malaysia Diaphragm Pacing Therapy System Market

        • 7.4.12.1. Market Size and Forecast, By Product Type
        • 7.4.12.2. Market Size and Forecast, By Applications
        • 7.4.12.3. Market Size and Forecast, By Methods

      • 7.4.13. Indonesia Diaphragm Pacing Therapy System Market

        • 7.4.13.1. Market Size and Forecast, By Product Type
        • 7.4.13.2. Market Size and Forecast, By Applications
        • 7.4.13.3. Market Size and Forecast, By Methods

      • 7.4.14. Rest of Asia Pacific Diaphragm Pacing Therapy System Market

        • 7.4.14.1. Market Size and Forecast, By Product Type
        • 7.4.14.2. Market Size and Forecast, By Applications
        • 7.4.14.3. Market Size and Forecast, By Methods

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Product Type

      • 7.5.3. Market Size and Forecast, By Applications

      • 7.5.4. Market Size and Forecast, By Methods

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Diaphragm Pacing Therapy System Market

        • 7.5.6.1. Market Size and Forecast, By Product Type
        • 7.5.6.2. Market Size and Forecast, By Applications
        • 7.5.6.3. Market Size and Forecast, By Methods

      • 7.5.7. South Africa Diaphragm Pacing Therapy System Market

        • 7.5.7.1. Market Size and Forecast, By Product Type
        • 7.5.7.2. Market Size and Forecast, By Applications
        • 7.5.7.3. Market Size and Forecast, By Methods

      • 7.5.8. Saudi Arabia Diaphragm Pacing Therapy System Market

        • 7.5.8.1. Market Size and Forecast, By Product Type
        • 7.5.8.2. Market Size and Forecast, By Applications
        • 7.5.8.3. Market Size and Forecast, By Methods

      • 7.5.9. UAE Diaphragm Pacing Therapy System Market

        • 7.5.9.1. Market Size and Forecast, By Product Type
        • 7.5.9.2. Market Size and Forecast, By Applications
        • 7.5.9.3. Market Size and Forecast, By Methods

      • 7.5.10. Argentina Diaphragm Pacing Therapy System Market

        • 7.5.10.1. Market Size and Forecast, By Product Type
        • 7.5.10.2. Market Size and Forecast, By Applications
        • 7.5.10.3. Market Size and Forecast, By Methods

      • 7.5.11. Rest of LAMEA Diaphragm Pacing Therapy System Market

        • 7.5.11.1. Market Size and Forecast, By Product Type
        • 7.5.11.2. Market Size and Forecast, By Applications
        • 7.5.11.3. Market Size and Forecast, By Methods

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Avery Biomedical Devices

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Lungpacer Medical, Inc

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Arahelio

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Synapse Biomedical

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Atrotech

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Boehringer Ingelheim

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Novartis

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. AstraZeneca

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Respironics

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. MedImmune

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

    • 9.11. Actelion

      • 9.11.1. Company Overview

      • 9.11.2. Key Executives

      • 9.11.3. Company Snapshot

      • 9.11.4. Operating Business Segments

      • 9.11.5. Product Portfolio

      • 9.11.6. Business Performance

      • 9.11.7. Key Strategic Moves and Developments

    • 9.12. Forest

      • 9.12.1. Company Overview

      • 9.12.2. Key Executives

      • 9.12.3. Company Snapshot

      • 9.12.4. Operating Business Segments

      • 9.12.5. Product Portfolio

      • 9.12.6. Business Performance

      • 9.12.7. Key Strategic Moves and Developments

    • 9.13. Pearl

      • 9.13.1. Company Overview

      • 9.13.2. Key Executives

      • 9.13.3. Company Snapshot

      • 9.13.4. Operating Business Segments

      • 9.13.5. Product Portfolio

      • 9.13.6. Business Performance

      • 9.13.7. Key Strategic Moves and Developments

    • 9.14. Ikaria

      • 9.14.1. Company Overview

      • 9.14.2. Key Executives

      • 9.14.3. Company Snapshot

      • 9.14.4. Operating Business Segments

      • 9.14.5. Product Portfolio

      • 9.14.6. Business Performance

      • 9.14.7. Key Strategic Moves and Developments

    • 9.15. Aeris

      • 9.15.1. Company Overview

      • 9.15.2. Key Executives

      • 9.15.3. Company Snapshot

      • 9.15.4. Operating Business Segments

      • 9.15.5. Product Portfolio

      • 9.15.6. Business Performance

      • 9.15.7. Key Strategic Moves and Developments

    • 9.16. PneumRx

      • 9.16.1. Company Overview

      • 9.16.2. Key Executives

      • 9.16.3. Company Snapshot

      • 9.16.4. Operating Business Segments

      • 9.16.5. Product Portfolio

      • 9.16.6. Business Performance

      • 9.16.7. Key Strategic Moves and Developments

    • 9.17. Pulmonx

      • 9.17.1. Company Overview

      • 9.17.2. Key Executives

      • 9.17.3. Company Snapshot

      • 9.17.4. Operating Business Segments

      • 9.17.5. Product Portfolio

      • 9.17.6. Business Performance

      • 9.17.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET FOR EXTERNAL DIAPHRAGM PACEMAKER, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET FOR DIAPHRAGM PACEMAKER, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET FOR SCI, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET FOR ALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET FOR OTHER, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET, BY METHODS, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET FOR INTRATHORACIC DIAPHRAGM PACING (IT-DP), BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET FOR INTRAPERITONEAL DIAPHRAGM PACING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. NORTH AMERICA DIAPHRAGM PACING THERAPY SYSTEM, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. NORTH AMERICA DIAPHRAGM PACING THERAPY SYSTEM, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 14. NORTH AMERICA DIAPHRAGM PACING THERAPY SYSTEM, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 15. NORTH AMERICA DIAPHRAGM PACING THERAPY SYSTEM, BY METHODS, 2025-2033 ($MILLION)
  • TABLE 16. U.S. DIAPHRAGM PACING THERAPY SYSTEM, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 17. U.S. DIAPHRAGM PACING THERAPY SYSTEM, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 18. U.S. DIAPHRAGM PACING THERAPY SYSTEM, BY METHODS, 2025-2033 ($MILLION)
  • TABLE 19. CANADA DIAPHRAGM PACING THERAPY SYSTEM, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 20. CANADA DIAPHRAGM PACING THERAPY SYSTEM, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 21. CANADA DIAPHRAGM PACING THERAPY SYSTEM, BY METHODS, 2025-2033 ($MILLION)
  • TABLE 22. MEXICO DIAPHRAGM PACING THERAPY SYSTEM, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 23. MEXICO DIAPHRAGM PACING THERAPY SYSTEM, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 24. MEXICO DIAPHRAGM PACING THERAPY SYSTEM, BY METHODS, 2025-2033 ($MILLION)
  • TABLE 25. EUROPE DIAPHRAGM PACING THERAPY SYSTEM, BY REGION, 2025-2033 ($MILLION)
  • TABLE 26. EUROPE DIAPHRAGM PACING THERAPY SYSTEM, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 27. EUROPE DIAPHRAGM PACING THERAPY SYSTEM, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 28. EUROPE DIAPHRAGM PACING THERAPY SYSTEM, BY METHODS, 2025-2033 ($MILLION)
  • TABLE 29. FRANCE DIAPHRAGM PACING THERAPY SYSTEM, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 30. FRANCE DIAPHRAGM PACING THERAPY SYSTEM, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 31. FRANCE DIAPHRAGM PACING THERAPY SYSTEM, BY METHODS, 2025-2033 ($MILLION)
  • TABLE 32. GERMANY DIAPHRAGM PACING THERAPY SYSTEM, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 33. GERMANY DIAPHRAGM PACING THERAPY SYSTEM, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 34. GERMANY DIAPHRAGM PACING THERAPY SYSTEM, BY METHODS, 2025-2033 ($MILLION)
  • TABLE 35. ITALY DIAPHRAGM PACING THERAPY SYSTEM, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 36. ITALY DIAPHRAGM PACING THERAPY SYSTEM, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 37. ITALY DIAPHRAGM PACING THERAPY SYSTEM, BY METHODS, 2025-2033 ($MILLION)
  • TABLE 38. SPAIN DIAPHRAGM PACING THERAPY SYSTEM, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 39. SPAIN DIAPHRAGM PACING THERAPY SYSTEM, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 40. SPAIN DIAPHRAGM PACING THERAPY SYSTEM, BY METHODS, 2025-2033 ($MILLION)
  • TABLE 41. UK DIAPHRAGM PACING THERAPY SYSTEM, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 42. UK DIAPHRAGM PACING THERAPY SYSTEM, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 43. UK DIAPHRAGM PACING THERAPY SYSTEM, BY METHODS, 2025-2033 ($MILLION)
  • TABLE 44. RUSSIA DIAPHRAGM PACING THERAPY SYSTEM, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 45. RUSSIA DIAPHRAGM PACING THERAPY SYSTEM, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 46. RUSSIA DIAPHRAGM PACING THERAPY SYSTEM, BY METHODS, 2025-2033 ($MILLION)
  • TABLE 47. REST OF EUROPE DIAPHRAGM PACING THERAPY SYSTEM, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 48. REST OF EUROPE DIAPHRAGM PACING THERAPY SYSTEM, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 49. REST OF EUROPE DIAPHRAGM PACING THERAPY SYSTEM, BY METHODS, 2025-2033 ($MILLION)
  • TABLE 50. ASIA-PACIFIC DIAPHRAGM PACING THERAPY SYSTEM, BY REGION, 2025-2033 ($MILLION)
  • TABLE 51. ASIA-PACIFIC DIAPHRAGM PACING THERAPY SYSTEM, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 52. ASIA-PACIFIC DIAPHRAGM PACING THERAPY SYSTEM, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 53. ASIA-PACIFIC DIAPHRAGM PACING THERAPY SYSTEM, BY METHODS, 2025-2033 ($MILLION)
  • TABLE 54. CHINA DIAPHRAGM PACING THERAPY SYSTEM, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 55. CHINA DIAPHRAGM PACING THERAPY SYSTEM, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 56. CHINA DIAPHRAGM PACING THERAPY SYSTEM, BY METHODS, 2025-2033 ($MILLION)
  • TABLE 57. JAPAN DIAPHRAGM PACING THERAPY SYSTEM, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 58. JAPAN DIAPHRAGM PACING THERAPY SYSTEM, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 59. JAPAN DIAPHRAGM PACING THERAPY SYSTEM, BY METHODS, 2025-2033 ($MILLION)
  • TABLE 60. INDIA DIAPHRAGM PACING THERAPY SYSTEM, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 61. INDIA DIAPHRAGM PACING THERAPY SYSTEM, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 62. INDIA DIAPHRAGM PACING THERAPY SYSTEM, BY METHODS, 2025-2033 ($MILLION)
  • TABLE 63. SOUTH KOREA DIAPHRAGM PACING THERAPY SYSTEM, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 64. SOUTH KOREA DIAPHRAGM PACING THERAPY SYSTEM, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 65. SOUTH KOREA DIAPHRAGM PACING THERAPY SYSTEM, BY METHODS, 2025-2033 ($MILLION)
  • TABLE 66. AUSTRALIA DIAPHRAGM PACING THERAPY SYSTEM, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 67. AUSTRALIA DIAPHRAGM PACING THERAPY SYSTEM, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 68. AUSTRALIA DIAPHRAGM PACING THERAPY SYSTEM, BY METHODS, 2025-2033 ($MILLION)
  • TABLE 69. THAILAND DIAPHRAGM PACING THERAPY SYSTEM, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 70. THAILAND DIAPHRAGM PACING THERAPY SYSTEM, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 71. THAILAND DIAPHRAGM PACING THERAPY SYSTEM, BY METHODS, 2025-2033 ($MILLION)
  • TABLE 72. MALAYSIA DIAPHRAGM PACING THERAPY SYSTEM, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 73. MALAYSIA DIAPHRAGM PACING THERAPY SYSTEM, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 74. MALAYSIA DIAPHRAGM PACING THERAPY SYSTEM, BY METHODS, 2025-2033 ($MILLION)
  • TABLE 75. INDONESIA DIAPHRAGM PACING THERAPY SYSTEM, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 76. INDONESIA DIAPHRAGM PACING THERAPY SYSTEM, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 77. INDONESIA DIAPHRAGM PACING THERAPY SYSTEM, BY METHODS, 2025-2033 ($MILLION)
  • TABLE 78. REST OF ASIA PACIFIC DIAPHRAGM PACING THERAPY SYSTEM, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 79. REST OF ASIA PACIFIC DIAPHRAGM PACING THERAPY SYSTEM, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 80. REST OF ASIA PACIFIC DIAPHRAGM PACING THERAPY SYSTEM, BY METHODS, 2025-2033 ($MILLION)
  • TABLE 81. LAMEA DIAPHRAGM PACING THERAPY SYSTEM, BY REGION, 2025-2033 ($MILLION)
  • TABLE 82. LAMEA DIAPHRAGM PACING THERAPY SYSTEM, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 83. LAMEA DIAPHRAGM PACING THERAPY SYSTEM, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 84. LAMEA DIAPHRAGM PACING THERAPY SYSTEM, BY METHODS, 2025-2033 ($MILLION)
  • TABLE 85. BRAZIL DIAPHRAGM PACING THERAPY SYSTEM, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 86. BRAZIL DIAPHRAGM PACING THERAPY SYSTEM, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 87. BRAZIL DIAPHRAGM PACING THERAPY SYSTEM, BY METHODS, 2025-2033 ($MILLION)
  • TABLE 88. SOUTH AFRICA DIAPHRAGM PACING THERAPY SYSTEM, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 89. SOUTH AFRICA DIAPHRAGM PACING THERAPY SYSTEM, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 90. SOUTH AFRICA DIAPHRAGM PACING THERAPY SYSTEM, BY METHODS, 2025-2033 ($MILLION)
  • TABLE 91. SAUDI ARABIA DIAPHRAGM PACING THERAPY SYSTEM, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 92. SAUDI ARABIA DIAPHRAGM PACING THERAPY SYSTEM, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 93. SAUDI ARABIA DIAPHRAGM PACING THERAPY SYSTEM, BY METHODS, 2025-2033 ($MILLION)
  • TABLE 94. UAE DIAPHRAGM PACING THERAPY SYSTEM, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 95. UAE DIAPHRAGM PACING THERAPY SYSTEM, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 96. UAE DIAPHRAGM PACING THERAPY SYSTEM, BY METHODS, 2025-2033 ($MILLION)
  • TABLE 97. ARGENTINA DIAPHRAGM PACING THERAPY SYSTEM, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 98. ARGENTINA DIAPHRAGM PACING THERAPY SYSTEM, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 99. ARGENTINA DIAPHRAGM PACING THERAPY SYSTEM, BY METHODS, 2025-2033 ($MILLION)
  • TABLE 100. REST OF LAMEA DIAPHRAGM PACING THERAPY SYSTEM, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 101. REST OF LAMEA DIAPHRAGM PACING THERAPY SYSTEM, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 102. REST OF LAMEA DIAPHRAGM PACING THERAPY SYSTEM, BY METHODS, 2025-2033 ($MILLION)
  • TABLE 103. AVERY BIOMEDICAL DEVICES: KEY EXECUTIVES
  • TABLE 104. AVERY BIOMEDICAL DEVICES: COMPANY SNAPSHOT
  • TABLE 105. AVERY BIOMEDICAL DEVICES: OPERATING SEGMENTS
  • TABLE 106. AVERY BIOMEDICAL DEVICES: PRODUCT PORTFOLIO
  • TABLE 107. AVERY BIOMEDICAL DEVICES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 108. LUNGPACER MEDICAL, INC: KEY EXECUTIVES
  • TABLE 109. LUNGPACER MEDICAL, INC: COMPANY SNAPSHOT
  • TABLE 110. LUNGPACER MEDICAL, INC: OPERATING SEGMENTS
  • TABLE 111. LUNGPACER MEDICAL, INC: PRODUCT PORTFOLIO
  • TABLE 112. LUNGPACER MEDICAL, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 113. ARAHELIO: KEY EXECUTIVES
  • TABLE 114. ARAHELIO: COMPANY SNAPSHOT
  • TABLE 115. ARAHELIO: OPERATING SEGMENTS
  • TABLE 116. ARAHELIO: PRODUCT PORTFOLIO
  • TABLE 117. ARAHELIO: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 118. SYNAPSE BIOMEDICAL: KEY EXECUTIVES
  • TABLE 119. SYNAPSE BIOMEDICAL: COMPANY SNAPSHOT
  • TABLE 120. SYNAPSE BIOMEDICAL: OPERATING SEGMENTS
  • TABLE 121. SYNAPSE BIOMEDICAL: PRODUCT PORTFOLIO
  • TABLE 122. SYNAPSE BIOMEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 123. ATROTECH: KEY EXECUTIVES
  • TABLE 124. ATROTECH: COMPANY SNAPSHOT
  • TABLE 125. ATROTECH: OPERATING SEGMENTS
  • TABLE 126. ATROTECH: PRODUCT PORTFOLIO
  • TABLE 127. ATROTECH: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 128. BOEHRINGER INGELHEIM: KEY EXECUTIVES
  • TABLE 129. BOEHRINGER INGELHEIM: COMPANY SNAPSHOT
  • TABLE 130. BOEHRINGER INGELHEIM: OPERATING SEGMENTS
  • TABLE 131. BOEHRINGER INGELHEIM: PRODUCT PORTFOLIO
  • TABLE 132. BOEHRINGER INGELHEIM: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 133. NOVARTIS: KEY EXECUTIVES
  • TABLE 134. NOVARTIS: COMPANY SNAPSHOT
  • TABLE 135. NOVARTIS: OPERATING SEGMENTS
  • TABLE 136. NOVARTIS: PRODUCT PORTFOLIO
  • TABLE 137. NOVARTIS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 138. ASTRAZENECA: KEY EXECUTIVES
  • TABLE 139. ASTRAZENECA: COMPANY SNAPSHOT
  • TABLE 140. ASTRAZENECA: OPERATING SEGMENTS
  • TABLE 141. ASTRAZENECA: PRODUCT PORTFOLIO
  • TABLE 142. ASTRAZENECA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 143. RESPIRONICS: KEY EXECUTIVES
  • TABLE 144. RESPIRONICS: COMPANY SNAPSHOT
  • TABLE 145. RESPIRONICS: OPERATING SEGMENTS
  • TABLE 146. RESPIRONICS: PRODUCT PORTFOLIO
  • TABLE 147. RESPIRONICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 148. MEDIMMUNE: KEY EXECUTIVES
  • TABLE 149. MEDIMMUNE: COMPANY SNAPSHOT
  • TABLE 150. MEDIMMUNE: OPERATING SEGMENTS
  • TABLE 151. MEDIMMUNE: PRODUCT PORTFOLIO
  • TABLE 152. MEDIMMUNE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 153. ACTELION: KEY EXECUTIVES
  • TABLE 154. ACTELION: COMPANY SNAPSHOT
  • TABLE 155. ACTELION: OPERATING SEGMENTS
  • TABLE 156. ACTELION: PRODUCT PORTFOLIO
  • TABLE 157. ACTELION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 158. FOREST: KEY EXECUTIVES
  • TABLE 159. FOREST: COMPANY SNAPSHOT
  • TABLE 160. FOREST: OPERATING SEGMENTS
  • TABLE 161. FOREST: PRODUCT PORTFOLIO
  • TABLE 162. FOREST: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 163. PEARL: KEY EXECUTIVES
  • TABLE 164. PEARL: COMPANY SNAPSHOT
  • TABLE 165. PEARL: OPERATING SEGMENTS
  • TABLE 166. PEARL: PRODUCT PORTFOLIO
  • TABLE 167. PEARL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 168. IKARIA: KEY EXECUTIVES
  • TABLE 169. IKARIA: COMPANY SNAPSHOT
  • TABLE 170. IKARIA: OPERATING SEGMENTS
  • TABLE 171. IKARIA: PRODUCT PORTFOLIO
  • TABLE 172. IKARIA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 173. AERIS: KEY EXECUTIVES
  • TABLE 174. AERIS: COMPANY SNAPSHOT
  • TABLE 175. AERIS: OPERATING SEGMENTS
  • TABLE 176. AERIS: PRODUCT PORTFOLIO
  • TABLE 177. AERIS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 178. PNEUMRX: KEY EXECUTIVES
  • TABLE 179. PNEUMRX: COMPANY SNAPSHOT
  • TABLE 180. PNEUMRX: OPERATING SEGMENTS
  • TABLE 181. PNEUMRX: PRODUCT PORTFOLIO
  • TABLE 182. PNEUMRX: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 183. PULMONX: KEY EXECUTIVES
  • TABLE 184. PULMONX: COMPANY SNAPSHOT
  • TABLE 185. PULMONX: OPERATING SEGMENTS
  • TABLE 186. PULMONX: PRODUCT PORTFOLIO
  • TABLE 187. PULMONX: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET SEGMENTATION
  • FIGURE 2. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET
  • FIGURE 3. SEGMENTATION DIAPHRAGM PACING THERAPY SYSTEM MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN DIAPHRAGM PACING THERAPY SYSTEM MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALDIAPHRAGM PACING THERAPY SYSTEM MARKET
  • FIGURE 11. DIAPHRAGM PACING THERAPY SYSTEM MARKET SEGMENTATION, BY BY PRODUCT TYPE
  • FIGURE 12. DIAPHRAGM PACING THERAPY SYSTEM MARKET FOR EXTERNAL DIAPHRAGM PACEMAKER, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. DIAPHRAGM PACING THERAPY SYSTEM MARKET FOR DIAPHRAGM PACEMAKER, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. DIAPHRAGM PACING THERAPY SYSTEM MARKET SEGMENTATION, BY BY APPLICATIONS
  • FIGURE 15. DIAPHRAGM PACING THERAPY SYSTEM MARKET FOR SCI, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. DIAPHRAGM PACING THERAPY SYSTEM MARKET FOR ALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. DIAPHRAGM PACING THERAPY SYSTEM MARKET FOR OTHER, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. DIAPHRAGM PACING THERAPY SYSTEM MARKET SEGMENTATION, BY BY METHODS
  • FIGURE 19. DIAPHRAGM PACING THERAPY SYSTEM MARKET FOR INTRATHORACIC DIAPHRAGM PACING (IT-DP), BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. DIAPHRAGM PACING THERAPY SYSTEM MARKET FOR INTRAPERITONEAL DIAPHRAGM PACING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 22. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 23. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 24. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 25. COMPETITIVE DASHBOARD
  • FIGURE 26. COMPETITIVE HEATMAP: DIAPHRAGM PACING THERAPY SYSTEM MARKET
  • FIGURE 27. TOP PLAYER POSITIONING, 2024
  • FIGURE 28. AVERY BIOMEDICAL DEVICES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 29. AVERY BIOMEDICAL DEVICES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 30. AVERY BIOMEDICAL DEVICES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 31. LUNGPACER MEDICAL, INC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 32. LUNGPACER MEDICAL, INC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 33. LUNGPACER MEDICAL, INC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 34. ARAHELIO: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 35. ARAHELIO: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 36. ARAHELIO: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 37. SYNAPSE BIOMEDICAL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 38. SYNAPSE BIOMEDICAL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 39. SYNAPSE BIOMEDICAL: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 40. ATROTECH: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 41. ATROTECH: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 42. ATROTECH: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 43. BOEHRINGER INGELHEIM: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 44. BOEHRINGER INGELHEIM: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 45. BOEHRINGER INGELHEIM: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 46. NOVARTIS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 47. NOVARTIS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 48. NOVARTIS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 49. ASTRAZENECA: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 50. ASTRAZENECA: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 51. ASTRAZENECA: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 52. RESPIRONICS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 53. RESPIRONICS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 54. RESPIRONICS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 55. MEDIMMUNE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 56. MEDIMMUNE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 57. MEDIMMUNE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 58. ACTELION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 59. ACTELION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 60. ACTELION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 61. FOREST: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 62. FOREST: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 63. FOREST: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 64. PEARL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 65. PEARL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 66. PEARL: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 67. IKARIA: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 68. IKARIA: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 69. IKARIA: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 70. AERIS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 71. AERIS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 72. AERIS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 73. PNEUMRX: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 74. PNEUMRX: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 75. PNEUMRX: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 76. PULMONX: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 77. PULMONX: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 78. PULMONX: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Diaphragm Pacing Therapy System Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved